Application of the digital annealer unit in optimizing chemical reaction conditions for enhanced production yields.

Journal: Journal of cheminformatics
Published Date:

Abstract

Finding optimal reaction conditions is crucial for chemical synthesis in the pharmaceutical and chemical industries. However, due to the vast chemical space, conducting experiments for all the possible combinations is impractical. Thus, quantitative structure-activity relationship (QSAR) models have been widely used to predict product yields, but evaluating all combinations is still computationally intensive. In this work, we demonstrate the use of Digital Annealer Unit (DAU) can tackle these large-scale optimization problems more efficiently. Two types of models are developed and tested on high-throughput experimentation (HTE) and Reaxys datasets. Our results suggest that the performance of models is comparable to classical machine learning (ML) methods (i.e., Random Forest and Multilayer Perceptron (MLP)), while the inference time of our models requires only seconds with a DAU. In active learning and autonomous reaction condition design, our model shows improvement for reaction yield prediction by incorporating new data, meaning that it can potentially be used in iterative processes. Our method can also accelerate the screening of billions of reaction conditions, achieving speeds millions of times faster than traditional computing units in identifying superior conditions.

Authors

  • Shih-Cheng Li
    Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
  • Pei-Hua Wang
    Undergraduate Program in Intelligent Computing and Big Data, Chung Yuan Christian University, No. 200, Zhongbei Road, Taoyuan, 320314, Taiwan.
  • Jheng-Wei Su
    Quantum Information Center, Chung Yuan Christian University, No. 200, Zhongbei Rd., Zhongli Dist., Taoyuan, 320314, Taiwan.
  • Wei-Yin Chiang
    Hon Hai (Foxconn) Research Institute, Taipei 114699, Taiwan.
  • Tzu-Lan Yeh
    Insilico Medicine Taiwan Ltd, Suite C830, 8F., No. 563, Sec. 4, Zhongxiao East Road, Xinyi District, Taipei, 110058, Taiwan.
  • Alex Zhavoronkov
    Pharmaceutical Artificial Intelligence Department, Insilico Medicine, Inc., Emerging Technology Centers, Johns Hopkins University at Eastern, Baltimore, Maryland, USA.
  • Shih-Hsien Huang
    Insilico Medicine Taiwan Ltd, Suite C830, 8F., No. 563, Sec. 4, Zhongxiao East Road, Xinyi District, Taipei, 110058, Taiwan.
  • Yen-Chu Lin
    Insilico Medicine Taiwan Ltd., Taipei 110208, Taiwan.
  • Chia-Ho Ou
    Department of Computer Science and Information Engineering, National Pingtung University, No.4-18, Minsheng Rd.Pingtung County, Pingtung, 900391, Taiwan.
  • Chih-Yu Chen
    Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, Department of Medical Genetics, University of British Columbia Vancouver, British Columbia V5Z 4H4, Canada. Electronic address: juliec@cmmt.ubc.ca.

Keywords

No keywords available for this article.